Wed, Jul 23, 2014, 4:47 PM EDT - U.S. Markets closed

Recent

% | $
Click the to save as a favorite.

Omeros Corporation (OMER) Message Board

rrtzrealmd 95 posts  |  Last Activity: 4 hours ago Member since: Aug 24, 2011
  • Reply to

    Vital Therapies

    by braksir1 Apr 17, 2014 10:17 AM
    rrtzrealmd rrtzrealmd Jun 6, 2014 12:09 AM Flag

    ...it's on their website...note that you can probably spit farther than you can trust positive results from ANY study done in China...also note that the paper included three VTL employees -- no chance of bias there, huh?...

  • Reply to

    Vital Therapies

    by braksir1 Apr 17, 2014 10:17 AM
    rrtzrealmd rrtzrealmd Jun 6, 2014 12:07 AM Flag

    ...oh, yes, several...largest is Millipore and Pharmacell collaboration...the University of Pretoria used to have one of their own design for sale to interested entrepreneurs -- in case you're interested in going into the biotech scam business.

    Sentiment: Strong Sell

  • VTL's "artificial liver"????

    Warning signs -- first, publications. Two in 12 YEARS. The first one in 2002 was just a safety study that reported some results from five patients but nothing of relevance to patient outcome. The second was from 2007 -- " Interim Results of Randomized Controlled Trial of ELAD in Acute on Chronic Liver Disease" -- and reported some remarkable results. Problems -- it was done in CHINA (I note sudden flare of large red flashing lights in my peripheral vision) and the authors included THREE Vital Therapies' employees (whoa!...now I'm hearing very loud sirens!).

    Second -- presentations. From 2010 -- "Safety and Efficacy of the Extacorporeal Liver Assist Device (ELAD®) in patients with Acute on Chronic Liver Failure" -- "survival data encouraging." Using the word "encouraging" when describing study results usually means it's NOT "encouraging." Interesting conclusions that the authors came to regarding future study design -- enroll patients with fewer complications, enroll patients with lower "model for end-stage liver disease" scores, use "prevention of disease progression" PRIOR to transplant/death as the primary endpoint. In other words, avoid sick patients, avoid patients whose livers are too far gone, and use "progression" rather than survival as an end-point. Why, of course! Why not exclude liver patients entirely and just drag in some perfectly healthy souls off the street -- that should produce GREAT results!

    I guess the FDA didn't buy VTL's logic entirely because the presentations from 2012 and 2013 can be came to the same conclusion: "Differences in survival were NOT statistically significant." Is there any reason to believe that a phase 3 study will alter that conclusion? None that I can think of.

    How does wall street manage to sell this stuff? It just amazes me that ANYONE with an IQ greater than a grapenut would plunk down even a nickel for this stock!

  • ...just THIRTEEN DOLLARS???...per SHARE???...is that right?...oh, wow!...like yeah, sign me up to buy a few hundred thousand shares -- NOT!!!...and the CEO gets paid HOW MUCH a year?...note for my "to do" list -- take some loser company public and pay myself a LOT of money to make it an even BIGGER loser!...

  • ...I'm soooooooo surprised:

    "This prospectus relates to the offer for sale of up to a potential aggregate of 3,897,172 shares of common stock, par value $.0001 per share, of LabStyle Innovations Corp. by the selling stockholders named herein...We will not receive any proceeds from the sales of the above shares of our common stock by the selling shareholders."

  • ...about "national approval and regional reimbursement" in ITALY!...well, whooptedoo!...given Italy is just socialized medicine, that's about as exciting as announcing that the CEO's dog just took a dump in the middle of the street!...can't wait until they announce it's "approved" in Albania!...

  • rrtzrealmd by rrtzrealmd Jun 3, 2014 8:55 PM Flag

    ...seventy CENTS in only two weeks of trading!...is that some sort of record or what?...what is it they're working on?...rose bengal?...for cancer??...the stuff they use to stain eyeballs when looking for corneal abrasions and such???......for CANCER????...uhhhhh, hold on a second..................ahem!..............................not much longer now!.............................................okay!...here it comes:

    HAW, HAW, HAW, HAW, HAW, HAW , HAW, HAW, HAW, HAW, HAW, HAW, HAW, HAW , HAW, HAW, HAW, HAW, HAW, HAW, HAW, HAW , HAW, HAW, HAW, HAW, HAW, HAW, HAW, HAW , HAW, HAW, HAW, HAW, HAW, HAW, HAW, HAW , HAW, HAW, HAW, HAW, HAW, HAW, HAW, HAW , HAW, HAW, HAW, HAW, HAW, HAW, HAW, HAW , HAW, HAW, HAW, HAW, HAW, HAW, HAW, HAW , HAW, HAW, HAW, HAW, HAW, HAW, HAW, HAW , HAW, HAW, HAW, HAW, HAW, HAW, HAW, HAW , HAW, HAW, HAW, HAW, HAW, HAW, HAW, HAW , HAW, HAW, HAW, HAW, HAW, HAW, HAW, HAW , HAW, HAW, HAW, HAW, HAW, HAW, HAW, HAW , HAW, HAW!!!!!!!!!!!!

    ...oh, that was a good one!...man, I think I need to go change my depends!!!...rose bengal!...well, what else could you expect from the biotech braintrust in KNOXVILLE, Tennessee?!...HAW!!!...

    Sentiment: Strong Sell

  • rrtzrealmd rrtzrealmd Jun 2, 2014 9:26 PM Flag

    ...seriously?...you think Allergan or any other pharma couldn't mix a couple of antique generic drugs and get it FDA approved IF they thought it was worth the money?...big pharma recognizes the "bottom line" -- what counts isn't FDA approval, it's third party reimbursement...and if you think medicare and insurance companies are going to fork over $250 for a half gallon of water containing a dime's worth of drugs, better think again...

  • Reply to

    Looking to buy here

    by bestinvestor14 Jun 2, 2014 10:48 AM
    rrtzrealmd rrtzrealmd Jun 2, 2014 11:53 AM Flag

    ...who cares...figure 52 million in cash but 32 million in DEBT at end of March!...burning 16 million a quarter means -- on balance -- they're now approaching BROKE -- AGAIN!...which no doubt means it's time to start chaining together some meaningless press releases in order to get ready to print some more stock!...let's see -- shares outstanding 2010 22 million, 2011 22 million, 2012 26 million, 2013 30 million, end of March 33 million...so before December figure another -- what? -- 5 million or so?...

  • ...SCAM this company is? Geez! Six to $32 and back again -- what a racket! Of course, the brokers banking commissions probably laughed themselves silly the entire time! Nevertheless, given the REAL value of this company is LESS than ZERO, there's plenty of downside left. What truly amazes me is how these things ever manage to come public to begin with!

  • rrtzrealmd by rrtzrealmd May 28, 2014 11:01 AM Flag

    ...well, the bid's up to $20...I'm certainly not complaining since I originally bought it around $15 a little over a year ago...but still, I''ve seen assorted mergers where banks like TRVR were taken over at amazing prices...not only that, TRVR was trading around $30 before the financial crisis and handled the crisis pretty well -- now has no preferred stock...earned 85 cents per share last quarter...growing insurance susidiary did have some bad news -- cancellation of Wellmark contract probably due to Obamacre...book value around $28...not as big a bargain as at $15 but still looking worthy if patient...very patient?...

  • Reply to

    Dang! I'm rich!

    by rrtzrealmd May 16, 2014 11:21 AM
    rrtzrealmd rrtzrealmd May 28, 2014 10:41 AM Flag

    Took over a month off to have some RnR and now I almost regret it! Getting back into the harness is NOT fun! Right now I'm mostly in some closed end bond funds -- JPI, JPW, HPF -- as well as some closed end funds focussed on MLPs -- MIE, SMM -- and a few speculative REITs -- WHLR, CGG. No VRTU at the moment but I'll be looking at it and some others again as soon as I get over feeling sorry for myself.

  • rrtzrealmd by rrtzrealmd May 16, 2014 11:21 AM Flag

    Well, may that's an exaggeration, but come back from vacation and see a big bump in my brokerage account and wonder what happened and of all the possibilities, it's mostly due to FUR! FUR? An REIT???? Up thirty some per cent????? Amazing! I'm going to have to go on vacation more often!

  • ...got ahead of itself north of $30...attractive around $20 with $6 a share in cash, increasing revenues, increasing profits...worthy speculation...

  • rrtzrealmd by rrtzrealmd May 16, 2014 10:59 AM Flag

    ...WOW!...nice timing, dude!...DOWN almost TWENTY FIVE per cent in the week and a half since you posted that!...HAW!!!...at that rate it won't take hardly any time for gOMER to reach where it belongs -- i.e. at ZERO!...HAW, HAW, HAW!!!...

OMER
14.35+0.62(+4.52%)4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.